Study to evaluate the awareness and knowledge towards cervical cancer, Human Papillomavirus and HPV vaccines among different healthcare workers.

Awareness and Knowledge about Cervical Cancer, Human Papillomavirus (HPV) and HPV vaccines among Medical personnel.

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2012/12/003269

Enrollment

400

Registered

2012-12-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Quadrivalent and bivalent HPV vaccines: Awareness and Knowledge about Cervical Cancer, Human Papillomavirus (HPV) and HPV vaccines among medical personnel. Control Intervention1: Quadri

Eligibility

Inclusion criteria

Inclusion criteria: 1. Able to fill the questionnaires used in this study. 2. Able to give a written informed consent. 3. Medical personnel from health care hospitals.

Exclusion criteria

Exclusion criteria: 1. Participants will be excluded if they are unable to provide written informed consent.

Design outcomes

Primary

Measure	Time frame
Analysis of knowledge and awareness regarding cervical cancer, HPV and HPV vaccines among medical personnelTimepoint: 6 months	—

Secondary

Measure	Time frame
1.Analysis of the use and types of contraceptives to prevent sexual transmitted infections. 2.Analysis of the attitudes towards sex education to their children. 3.Analysis of the attitudes towards HPV vaccines use. 4.Analysis of the willingness of HPV vaccines. 5.Analysis of the utilization of HPV vaccines. 6.Analysis of barriers for HPV vaccination. 7.Analysis of the acceptance of HPV vaccines.Timepoint: 6 months	—

Measure

Time frame

1.Analysis of the use and types of contraceptives to prevent sexual transmitted infections. 2.Analysis of the attitudes towards sex education to their children. 3.Analysis of the attitudes towards HPV vaccines use. 4.Analysis of the willingness of HPV vaccines. 5.Analysis of the utilization of HPV vaccines. 6.Analysis of barriers for HPV vaccination. 7.Analysis of the acceptance of HPV vaccines.Timepoint: 6 months

—

Countries

India

Contacts

Public ContactVikrant Chandrakant Sangar

vikrant_sangar2010@yahoo.com9623265391

Outcome results